RP-HPLC Method Development and Validation for Determination of Eptifibatide Acetate in Bulk Drug Substance and Pharmaceutical Dosage Forms.

about

RP-HPLC Method Development and Validation for Determination of Eptifibatide Acetate in Bulk Drug Substance and Pharmaceutical Dosage Forms.

Item

http://www.wikidata.org/entity/Q42360543

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

RP-HPLC Method Development and ...... d Pharmaceutical Dosage Forms.

@en

RP-HPLC Method Development and ...... d Pharmaceutical Dosage Forms.

@nl

type

Item

label

RP-HPLC Method Development and ...... d Pharmaceutical Dosage Forms.

@en

RP-HPLC Method Development and ...... d Pharmaceutical Dosage Forms.

@nl

prefLabel

RP-HPLC Method Development and ...... d Pharmaceutical Dosage Forms.

@en

RP-HPLC Method Development and ...... d Pharmaceutical Dosage Forms.

@nl

P1476

RP-HPLC Method Development and ...... d Pharmaceutical Dosage Forms.

@en

P2093

Abdul Majid Ayatollahi

http://www.w3.org/2001/XMLSchema#string

Farzad Kobarfard

http://www.w3.org/2001/XMLSchema#string

Hossein Vahidi

http://www.w3.org/2001/XMLSchema#string

Maryam Bavand Savadkouhi

http://www.w3.org/2001/XMLSchema#string

Shirin Hooshfar

http://www.w3.org/2001/XMLSchema#string

P2860

Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents.

Characterization of eptifibatide during drug formulation stability assays.

Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use?

Clinical pharmacology of eptifibatide.

Development of eptifibatide.

Development and Validation of a Reversed-phase HPLC Method for Assay of the Decapeptide Cetrorelix Acetate in Bulk and Pharmaceutical Dosage Forms.

Improved liquid chromatography-tandem mass spectrometry method for the analysis of eptifibatide in human plasma.

Stabilization of eptifibatide by cosolvents.

Determination of eptifibatide concentration in human plasma utilizing the liquid chromatography-tandem mass spectrometry method.

P304

490-497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28979304

http://www.w3.org/2001/XMLSchema#string

P932

5603858

http://www.w3.org/2001/XMLSchema#string